Table 2.
Clinical outcome of de novo myeloid acute leukemia patients
| Characteristics | Non‐methylated n (%) | Methylated n (%) | P‐value |
|---|---|---|---|
| Induction response | NS | ||
| Complete remission | 72 (50) | 63 (59) | |
| Failure | |||
| Resistance | 21 (14) | 18 (17) | |
| Death | 19 (13) | 8 (7) | |
| Not treated | 33 (23) | 18 (17) | |
| Post‐induction therapy | NS | ||
| Chemotherapy only | 66 (46) | 56 (52) | |
| Autologous SCT | 22 (15) | 16 (15) | |
| Allogenic SCT | 22 (15) | 17 (16) | |
| Relapse | 22 (15) | 40 (37) | <0.001 |
| Death | 89 (61) | 85 (79) | 0.004 |
NS, not significant; SCT, stem cell transplantation.